Proteomics and cancer diagnosis: The potential of mass spectrometry

Clinical Biochemistry

Volumn 37, Issue 7, 2004, Pages 579-583

  Rodland, Karin D ^a,b  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b U S DEPARTMENT OF ENERGY   (United States)

Author keywords

Biomarkers; Mass spectrometry; Proteomics; Tumor markers

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

AFFINITY CHROMATOGRAPHY; ALGORITHM; CANCER DIAGNOSIS; CANCER STAGING; HUMAN; INFORMATION SCIENCE; MASS SPECTROMETRY; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION MASS SPECTROMETRY; TUMOR CELL; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS;

ALGORITHMS; CHROMATOGRAPHY, AFFINITY; COMPUTATIONAL BIOLOGY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FORECASTING; HUMANS; MASS SPECTROMETRY; NEOPLASMS; PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 3042829216     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.05.011     Document Type: Review

References (37)

1. Stamey T.A., Johnstone I.M., McNeal J.E., Lu A.Y., Yemoto C.M. Preoperative serum prostate specific antigen levels between 2 and 22 ng/ml correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng/ml. J. Urol. 167:2002;103-111
2. Hanash S. Biomedical applications of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 21:2000;102-109
3. Adam B., Vlahou A., Semmes O., Wright G. Jr. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics. 1:2001;1264-1270
4. Charrier J., Tournel C., Michel S., Comby S., Jolivet-Reynaud C., Passagot J., et al. Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis. Electrophoresis. 22:2001;1861-1866
5. Kuere H., Goldknopf I., H F., S K., Sheta E., Hunt K. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. Cancer. 95:2002;2276-2282
6. Ou K., Seow T.K., Liang R.C., Ong S.E., Chung M.C. Proteome analysis of a human hepatocellular carcinoma cell line, HCC-M. Electrophoresis. 22:2001;2804-2811
7. Zhou G., Li H., DeCamp D., Chen S., Shu H., Gong Y., et al. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics. 1:2002;117-124
8. Chen G., Gharib T., Huang C., Thomas D., Shedden K., Taylor J., et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 7:2002;2298-2305
9. Oh J.M., Brichory F., Puravs E., Kuick R., Wood C., Rouillard J., et al. A database of protein expression in lung cancer. Proteomics. 2001;1
10. Zhang R., Tremblay T., McDermid A., Thibault P., Stnimirovic D. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia. 2003;42
11. Gygi S.P., Corthals G.L., Zhang Y., Rochon Y., Aebersold R. Evaluation of tw0-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. U. S. A. 97:2000;9390-9395
12. Chong B.E., Lubman D.M., Rosenspire A., Miller F. Protein profiles and identification of high performance liquid chromatography isolated cancer cell lines using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 12:1998;1986-1993
13. O'Neil K.A., MIiller F.R., Barder T.J., Lubman D.M. Profiling the progression of cancer: separation of microsomal proteins in MCF10 breast epithelial cell lines using nonporous chromatophoresis. Proteomics. 3:2003;1256-1269
14. Zhu K., Kim J., Yoo C., Miller F.R., Lubman D.M. High sequence coverage of proteins isolated from liquid separations of breast cancer cells using capillary electrophoresis-time-of-flight MS and MALDI-TOF MS mapping. Anal. Chem. 75:2003;6209-6217
15. Conrads T.P., Anderson G.A., Veenstra T.D., Pasa-Tolic L., Smith R.D. Utility of accurate mass tags for proteome-wide protein identification. Anal. Chem. 72:2000;3349-3354
16. Lipton M.S., Pasa-Tolic' L., Anderson G.A., Anderson D.J., Auberry D.L., Battista J.R., et al. Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10943-10954
17. Pieper R., Su Q., Gatlin C., Huang S., Anderson N., Steiner S. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics. 3:2003;422-432
18. Adkins J.N., Varnum S.M., Auberry K.J., Moore R.J., Angell N.H., Smith R.D., et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics. 1:2002;947-955
19. Sauter E., Zhu W., Fan X., Wassell R., Chervoneva I., Du Bois G. Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer. Br. J. Cancer. 86:2002;1440-1443
20. Varnum S., Covington C., Woodbury R., Petritis K., Kangas L., Abdullah M., et al. Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer. Breast Cancer Res. Treat. 80:2003;87-97
21. Issaq H., Veenstra T., Conrads T., Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292:2002;587-592
22. Hutchens T., Yip T. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun. Mass Spectrom. 7:1993;576-580
23. Petricoin E.I., Ornstein D., Paweletz C., Ardekani A., Hackett P., Hitt B. Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. 94:2002;1576-1578
24. Petricoin E., Paweletz C., Liotta L. Clinical applications of proteomics: proteomic pattern diagnostics. J. Mammary Gland Biol. Neoplasia. 7:2002;433-440
25. Wright G.J., Cazares L., Leung S., Nasim S., Adam B., Yip T. ProteinChip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis. 2:1999;264-276
26. Petricoin E.F., Ardekani A.M., Hitt B.A., LeVine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 359:2002;572-577
27. Zhang L., Rosenzweig J., Wang Y., Chan D. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48:2002;1296-1304
28. Wulfkuhle J., McLean K., Pawaletz C., Sgroi D., Trock B., Steeg P., et al. New approaches to proteomic analysis of breast cancer. Proteomics. 1:2001;1205-1215
29. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48:2002;1296-1304
30. Qu Y., Adam B.-L., Yasui Y., Ward M.D., Cazares L.H., F S.P., et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin. Chem. 48(10):2002;1835-1843
31. Sorace J.M., Zhan M. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics. 4:2003;24
32. Xu Y., Fang X.-J., Casey G., Mills G.B. Lysophospholipids activate ovarian and breast cancer cells. Biochem. J. 309:1995;933-940
33. Srinivas Pr., Srivastava S., Hanash S., Wright G.L.J. Proteomics in early detection of cancer. Clin. Chem. 47:2001;1901-1911
34. Srinivas P.R., Verma M., Zhao Y., Srivastava S. Proteomics for cancer biomarker discovery. Clin. Chem. 48:2002;1160-1169
35. Diamandis E.P. Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin. Chem. 49:2003;1272-1278
36. Petricoin E.I., Liotta L.A. Counterpoint: the vision for a new diagnostic paradigm. Clin. Chem. 49:2003;1279-1285
37. Anderson N., Anderson N. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics. 1:2002;845-867